International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
OpenAlex
Works that cite this article, indexed by OpenAlex.
Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review
Gland Surgery 9(5) (2020)
Faiza Rashid; Jijgee Munkhdelger; Junya Fukuoka; Andrey Bychkov
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
BMC Cancer 18(1) (2018)
Maryam Zarkesh; Azita Zadeh–Vakili; Mahdi Akbarzadeh; Seyed Ahmad Fanaei; Mehdi Hedayati; Fereidoun Azizi
TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
Frontiers in Endocrinology 13 (2022)
Sandeep Kumar Parvathareddy; Abdul K. Siraj; Kaleem Iqbal; Zeeshan Qadri; Saeeda Omer Ahmed; Maha M. Al-Rasheed; Ahmed AlQatie; Saif S. Al-Sobhi; Fouad Al‐Dayel; Khawla Sami Al-Kuraya
A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma
Endocrine 86(2) (2024)
Tahereh Haghzad; Babak Khorsand; Seyedeh Adeleh Razavi; Mehdi Hedayati
BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases
Life Sciences 223 (2019)
Maryam Zarkesh; Azita Zadeh–Vakili; Mahdi Akbarzadeh; Zahra Nozhat; Seyed Ahmad Fanaei; Mehdi Hedayati; Fereidoun Azizi
RAP1GAP Functions as a Tumor Suppressor Gene and Is Regulated by DNA Methylation in Differentiated Thyroid Cancer
Cytogenetic and Genome Research 161(5) (2021)
Bita Faam; Mohammad Ali Ghaffari; Layasadat Khorsandi; Ata Ghadiri; Mehdi Totonchi; Atieh Amouzegar; Seyed Ahmad Fanaei; Fereidoun Azizi; Hajeih B. Shahbazian; Mahmoud Hashemi Tabar
NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene
Intern J Endocrinol Metab 18(4) (2020)
Sara Sheikholeslami; Fereidoun Azizi; Asghar Ghasemi; Abbas Alibakhshi; Hossein Parsa; Seyed Mohammad Tavangar; Setareh Shivaee; Marjan Zarif Yeganeh; Mehdi Hedayati; Ladan Teimoori‐Toolabi
Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway
PLoS ONE 16(11) (2021)
Chakit Arora; Dilraj Kaur; Leimarembi Devi Naorem; Gajendra P. S. Raghava
CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review
Cancer Cell International 22(1) (2022)
Maryam Zarkesh; Noman Arab; Raziyeh Abooshahab; Shabnam Heydarzadeh; Sara Sheikholeslami; Zahra Nozhat; Marziyeh Salehi Jahromi; Seyed Ahmad Fanaei; Mehdi Hedayati
RET/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: a case report and review of the literature
Thyroid Research 16(1) (2023)
Maryam Kabootari; Reza Habibi Tirtashi; Azita Zadeh–Vakili; Maryam Zarkesh; Hossein Samadanifard; Shirin Haghighi; Fereidoun Azizi; Atieh Amouzegar
Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer
Environmental Toxicology 38(9) (2023)
Wenjie Jiang; Yan Yu; Adheesh Bhandari; Suzita Hirachan; Xubin Dong; Xiaoli Huang; Jinmiao Qu; Chengze Chen
Foxe1 deficiency impairs thyroid fate while supporting lung differentiation
EMBO Reports 27(15) (2026)
Bárbara F. Fonseca; Cindy Barbée; Sema Elif Eski; Pierre Gillotay; Daniel Monteyne; David L. Pérez-Morga; Samuel Refetoff; Sumeet Pal Singh; Sabine Costagliola; Mírian Romitti
Thyroid cancer: Advances in diagnostic research
Elsevier eBooks (2025)
Emmanuel Kwaku Ofori; Dziedzorm Wormenor; Eric Nana Yaw Nyarko
Epigenetic silencing of the tumor suppressor TIMP-3 gene in upstream CpG islands in thyroid neoplasms: a cross-sectional study with systematic review
Molecular Biology Reports 52(1) (2025)
Maryam Zarkesh; Noman Arab; Raziyeh Abooshahab; Shabnam Heydarzadeh; Zahra Nozhat; Marziyeh Salehi Jahromi; Mahdi Akbarzadeh; Seyed Ahmad Fanaei; Mehdi Hedayati